UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026892 |
|---|---|
| Receipt number | R000030850 |
| Scientific Title | Clinical study with subsequent subcutaneous administration of GEN0101 in the patients enrolled in the Phase 1 dose-escalation, safety / tolerability and preliminary efficacy study of intratumoral and subcutaneous administration of GEN0101 (GEN0101-JM003). |
| Date of disclosure of the study information | 2017/04/10 |
| Last modified on | 2023/06/01 16:15:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/04/07 08:02:35 | ||
| 2 | Update | 2017/04/07 08:16:50 | Last name of contact person |
|
| 3 | Update | 2017/05/23 16:48:22 | Recruitment status |
|
| 4 | Update | 2023/05/30 15:46:16 | UMIN ID1 |
|
| 5 | Update | 2023/06/01 15:37:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 6 | Update | 2023/06/01 16:13:38 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 7 | Update | 2023/06/01 16:15:08 | Email |
